Literature DB >> 15541328

Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus.

Chi Chiu Mok1, Sandy Shuk Kuen Tang.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15541328     DOI： 10.1016/j.amjmed.2004.04.029

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  13 in total

1.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.

Authors:  Christine Hsieh; Anthony Chang; Daniel Brandt; Riteesha Guttikonda; Tammy O Utset; Marcus R Clark
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

Review 2.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 3.  Biomarkers for lupus nephritis: a critical appraisal.

Authors:  Chi Chiu Mok
Journal:  J Biomed Biotechnol       Date:  2010-04-19

Review 4.  Overview of pathophysiology and treatment of human lupus nephritis.

Authors:  Kimberly Trotter; Marcus R Clark; Vladimir M Liarski
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 5.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.

Authors:  Chi Chiu Mok
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

6.  Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.

Authors:  Andrew J Kinloch; Anthony Chang; Kichul Ko; Carole J Henry Dunand; Scott Henderson; Mark Maienschein-Cline; Natalya Kaverina; Brad H Rovin; Marlene Salgado Ferrer; Don Wolfgeher; Vladimir Liarski; D James Haddon; Paul J Utz; Patrick C Wilson; Marcus R Clark
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

7.  Understanding lupus nephritis: diagnosis, management, and treatment options.

Authors:  Chi Chiu Mok
Journal:  Int J Womens Health       Date:  2012-05-22

8.  Calcineurin inhibitors may be a reasonable alternative to cyclophosphamide in the induction treatment of active lupus nephritis: A systematic review and meta-analysis.

Authors:  Min Yang; Min Li; Wei He; Bin Wang; Yong Gu
Journal:  Exp Ther Med       Date:  2014-04-07       Impact factor: 2.447

9.  High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus.

Authors:  Elkin Navarro-Quiroz; Lisandro Pacheco-Lugo; Hernan Lorenzi; Yirys Díaz-Olmos; Lisneth Almendrales; Edwin Rico; Roberto Navarro; Pierine España-Puccini; Antonio Iglesias; Eduardo Egea; Gustavo Aroca
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

10.  ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai.

Authors:  Wanling Yang; Minghui Zhao; Nattiya Hirankarn; Chak Sing Lau; Chi Chiu Mok; Tak Mao Chan; Raymond W S Wong; Ka Wing Lee; Mo Yin Mok; Sik Nin Wong; Yingyos Avihingsanon; Irene Oi Lin; Tsz Leung Lee; Marco Hok Kung Ho; Pamela Pui Wah Lee; Wilfred Hing Sang Wong; Pak Chung Sham; Yu Lung Lau
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.